N-cadherin inhibitors belong to a significant chemical class primarily known for their role in modulating cellular interactions within various physiological contexts. These inhibitors are designed to target N-cadherin, a type of transmembrane protein belonging to the cadherin superfamily. N-cadherin plays a pivotal role in mediating calcium-dependent cell-cell adhesion, crucial for maintaining tissue integrity and cellular architecture. The chemical compounds within this class are engineered to interfere with the adhesive properties of N-cadherin, thereby influencing cell adhesion processes and impacting various cellular mechanisms. By selectively disrupting N-cadherin interactions, these inhibitors have the ability to shed light on the intricate dynamics of cell adhesion and its implications in cellular behavior.
Structurally, N-cadherin inhibitors encompass a diverse range of compounds that exhibit specificity towards N-cadherin proteins. Through molecular modifications, these inhibitors are engineered to competitively bind to N-cadherin molecules, often at key binding domains, hindering their ability to engage in homophilic interactions with adjacent cells. This targeted interference may result in altered cellular arrangements and intercellular communication, which could have implications in developmental processes, tissue formation, and other physiological phenomena. Researchers are keenly interested in understanding the intricate mechanisms through which N-cadherin inhibitors operate, with the aim of unraveling the underlying principles of cell adhesion and its significance in various biological contexts. By elucidating the nuances of N-cadherin inhibition, scientists hope to gain valuable insights into fundamental cellular processes, paving the way for a deeper understanding of cellular dynamics beyond their adhesion roles.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
AZD4547 | 1035270-39-3 | sc-364421 sc-364421A | 5 mg 10 mg | $198.00 $309.00 | 6 | |
Suppresses N-cadherin signaling by targeting FGFR kinase. | ||||||
LY2157299 | 700874-72-2 | sc-391123 sc-391123A | 5 mg 10 mg | $213.00 $359.00 | 3 | |
Blocks N-cadherin expression via TGF-β receptor inhibition. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
Reduces N-cadherin levels by inhibiting GSK-3α and GSK-3β. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Disrupts N-cadherin-mediated signaling through Src inhibition. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
Inhibits N-cadherin expression via selective Cdc42 inhibition. | ||||||
TAE684 | 761439-42-3 | sc-364626 sc-364626A | 5 mg 50 mg | $188.00 $988.00 | 2 | |
Impairs N-cadherin signaling by targeting c-Met kinase. | ||||||
SB-3CT | 292605-14-2 | sc-205847 sc-205847A | 1 mg 5 mg | $102.00 $388.00 | 15 | |
Inhibits N-cadherin shedding through MMP-2 and MMP-9 blockade. | ||||||